Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 24, 1998

View Archived Issues

Procyon receives Japanese patent for prostate cancer treatment

PowderJect delivery of DNA vaccines validated in preclinical study

Expanded approval requested for chemoprotective agent

Myriad Genetics: Q4 and FY 1998 highlights

More on NPY receptor antagonists developed at Banyu

Mitsui Chemicals prepares cell adhesion inhibitors

Hydroxamic acids as cancer cell differentiation inducers under study at Mitsui Chemicals

Another series of DC-107 derivatives from Kyowa Hakko particularly useful as antitumor agents

Belgian academic researchers prepare bioisosteres of BM-34 as new anticonvulsants

OraPharma begins collaboration with U.N.C. for dental and related diseases

Isis Pharmaceuticals receives milestone payment from Ciba Vision for Vitravene

New paclitaxel formulation enters clinical trials

TheraTech receives NIH funding for novel approach to rheumatoid arthritis

Cangene signs WinRho distribution agreement for Australia

Biomira and Biovector collaborate on development of idiotypic B-cell lymphoma vaccine

Tranzyme obtains technology license from U. of Alabama

Enzon's PEG-Intron A advances to phase III trials for malignant melanoma

Phase III trials initiated for desloratadine

Pierre Fabre obtains good results with RSV subunit vaccine in monkey model

HemispheRx broadens hepatitis C portfolio

Meiji Seika profiles preclinical activity of new parenteral cephalosporin

Caelyx receives approval in Canada

Safety studies support pediatric use of MKC-442

Independent investigators report efficacy of Eisai cephalosporin

Postmarketing study of Vaqta supports safety of hepatitis A vaccine

Lobucavir is safe and effective in controlling herpes recurrences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...